Rodrigo Vincenzi, Eduardo A. Fonseca, Karina M. O. Roda, Paulo Chapchap and João Seda Neto* Pages 3402 - 3405 ( 4 )
The last decades have witnessed a significant improvement in the field of pediatric liver transplantation (LT), resulting in longer patient and graft survival; adequate graft selection, surgical refinement, the use of live donors and optimal postoperative care are among the reasons why pediatric recipients are living longer. With this new condition, pediatric recipients are now more exposed to the deleterious effects of immunosuppression, including metabolic, infectious and neoplastic complications, nephrotoxicity and neurotoxicity. Due to all those particularities, the approach to avoid overimmunosuppression or underimmunosuppression may be more difficult in children than in adult recipients. Moreover, pediatric recipients are exposed to growth issues and specific problems during adolescence, like nonadherence to immunosuppressive therapy. This article highlights the current immunosuppressive strategies for pediatric liver transplant recipients.
Liver transplantation, pediatric transplantation, immunosuppression, acute cellular rejection, chronic rejection, solid-organ transplant.
Liver Transplant Department, Hospital Sirio-Libanes, Sao Paulo, SP, Liver Transplant Department, Hospital Sirio-Libanes, Sao Paulo, SP, Liver Transplant Department, Hospital Sirio-Libanes, Sao Paulo, SP, Liver Transplant Department, Hospital Sirio-Libanes, Sao Paulo, SP, Liver Transplant Department, Hospital Sirio-Libanes, Sao Paulo, SP